Milestone in Hyperbaric Oxygenation: Sechrist Industries Delivers 1000th Model 3200 Chamber - The one-thousandth Model 3200 monoplace hyperbaric chamber to be designed and manufactured by HBO leader, Sechrist Industries, will be delivered to the Medical Center of Plano in Plano, Texas. The milestone, achieved by no other hyperbaric technology company, attests to the increasing demand for hyperbaric oxygenation in a wide variety of indications. Overall, Sechrist has delivered thousands of hyperbaric chambers, and the Sechrist Model 3200 is considered the gold standard of the industry. <MORE>

Sechrist Increases Focus on International Markets;
Appoints William Preuit Senior Vice President - Ed Pulwer, President and CEO of hyperbaric oxygenation leader Sechrist Industries today announced the strategic addition of William I. Preuit to the position of Senior Vice President of International Sales and Marketing. According to Pulwer, “The appointment of a leading marketing professional such as Bill to this position shows the importance Sechrist places on the international market. While we already have some significant market share outside the U.S., the growing list of applications for hyperbaric oxygenation makes this a vital technology for patient care all over the world. With Bill in leadership, we believe the international arena represents an area of substantial growth for Sechrist.” <MORE>

Sechrist Industries, World Leader in Hyperbaric Chambers,
Announces Edward Pulwer as President/CEO - “Hyperbaric medicine is just in its adolescence today and I see our company providing the technological platform for a wide range of future applications and global markets,” stated Edward Pulwer, upon accepting the position of President/CEO from the Board of Directors of Sechrist Industries. Sechrist, an over 30 year old company, maintains the largest installed base of single-place hyperbaric chambers worldwide and has, for many years, led the industry in innovation and technological advances in this complex medical platform.. <MORE>

Sechrist Introduces Ground-Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers - Sechrist Industries, world leader in technology for hyperbaric healthcare, today announced the availability of a new Patient & Chamber Ground-Check System which will provide verification of all NFPA (National Fire Protection Association) hyperbaric chamber ground requirements and the first to be fully integrated into any hyperbaric chamber. <MORE>

Sechrist Introduces Hyperbaric Industry's first Patient-Positioning Pads
The hyperbaric industry’s first ever patient positioning pads developed specifically for use in hyperbaric oxygen chambers have been introduced by Sechrist Industries, the world leader in hyperbaric chambers. The Sechrist HBO2 Patient Comfort Positioning Pads™ are available in three multifunctional configurations .<MORE>

Sechrist Introduces New OmniPressure Hyperbaric Chamber Mattress
A new hyperbaric chamber mattress designed to provide improved patient comfort and to support healthcare professionals in their wound-provention goals has been introduced by Sechrist Industries, the world leader in hyperbaric chamber.<MORE>

Sechrist Industries, Inc. awarded Premier Sole-Source Contract for Hyperbaric Oxygen Chambers - Sechrist Industies annouced that it has been awarded a new sole-source contract by Premier Purchasing Partners, L. P., the group purchasing unit of Premier Inc. The new agreement, effective October 1, 2008 through September 30, 2010, allows Sechrist to hyperbaric chambers .<MORE>

Diversified Clinical Services:  Strength in Numbers - Health Solution Spotlight
President Jeffrey Nelson explains how a merger enhanced this national wound care company’s ability to provide solutions to its customers.<MORE>

Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine and Stroke Victims - With the financial support of Sechrist Industries, Inc., The Center for Minimally Invasive Surgery (CMIS) at the Ohio State University Medical Center has begun testing the efficacy of hyperbaric oxygen medicine on experimental stroke models. <MORE>